The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 6: Transforming growth factor beta

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 28 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
93 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(83 more)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
92 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(82 more)
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
92 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(82 more)
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
14 A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
(4 more)
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
14 A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) A5YM40 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
(4 more)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
8 P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P17125 (/IPI)
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
7 P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI)
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
7 P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI)
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
1 T0MJ72 (/ISS)
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
1 G9KT38 (/ISS)
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
1 T0MJ72 (/ISS)
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
1 P17125 (/ISO)
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
1 T0MJ72 (/ISS)
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
1 Q07258 (/TAS)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
1 G9KT38 (/ISS)
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
1 P17125 (/ISO)
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
1 P17125 (/ISO)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
1 P17125 (/ISO)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
1 T0MJ72 (/ISS)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
1 Q07258 (/IDA)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
1 P17125 (/ISO)
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
1 P17125 (/ISO)

There are 206 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
101 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(91 more)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
101 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(91 more)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
100 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(90 more)
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
94 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(84 more)
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
93 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(83 more)
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
93 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(83 more)
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
93 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(83 more)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
92 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(82 more)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
92 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(82 more)
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
92 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(82 more)
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
9 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P15203 (/ISS) Q07258 (/ISS)
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
8 G9KT38 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
8 G9KT38 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
8 G9KT38 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
7 P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS)
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
7 P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
7 P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
7 P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
7 P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP)
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
7 P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
7 P10600 (/NAS) P10600 (/NAS) P10600 (/NAS) P10600 (/NAS) P10600 (/NAS) P10600 (/NAS) P10600 (/NAS)
Uterine wall breakdown GO:0042704
The sloughing of the endometrium and blood vessels during menstruation that results from a drop in progesterone levels.
7 P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
7 P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP)
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
7 P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS)
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
7 P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP)
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Positive regulation of tight junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of tight junction disassembly.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
2 P17125 (/IDA) Q07258 (/IDA)
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Regulation of ossification GO:0030278
Any process that modulates the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
2 Q66I23 (/IMP) Q7SZV3 (/IMP)
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
2 P17125 (/IMP) Q07258 (/IMP)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 P16047 (/IMP) P17125 (/IMP)
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Hematopoietic stem cell differentiation GO:0060218
The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
2 Q66I23 (/IGI) Q7SZV3 (/IGI)
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Regulation of cartilage development GO:0061035
Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
2 Q66I23 (/IMP) Q7SZV3 (/IMP)
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
1 G9KT38 (/ISS)
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
1 Q07258 (/IDA)
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
1 P17125 (/ISO)
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
1 T0MJ72 (/ISS)
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
1 T0MJ72 (/ISS)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 Q07258 (/IEP)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 P17125 (/ISO)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
1 P17125 (/IMP)
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
1 P16047 (/TAS)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 T0MJ72 (/ISS)
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
1 G9KT38 (/ISS)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
1 G9KT38 (/ISS)
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
1 T0MJ72 (/ISS)
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
1 G9KT38 (/ISS)
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
1 G9KT38 (/ISS)
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
1 T0MJ72 (/ISS)
Epithelial to mesenchymal transition involved in endocardial cushion formation GO:0003198
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of the endocardial cushion.
1 P16047 (/TAS)
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
1 T0MJ72 (/ISS)
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
1 G9KT38 (/ISS)
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
1 G9KT38 (/ISS)
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
1 G9KT38 (/ISS)
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
1 G9KT38 (/ISS)
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
1 G9KT38 (/ISS)
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
1 G9KT38 (/ISS)
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 P17125 (/ISO)
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
1 G9KT38 (/ISS)
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
1 G9KT38 (/ISS)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
1 P16047 (/TAS)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
1 T0MJ72 (/ISS)
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
1 Q07258 (/IEP)
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
1 Q07258 (/IEP)
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
1 T0MJ72 (/ISS)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P17125 (/ISO)
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
1 P17125 (/ISO)
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
1 T0MJ72 (/ISS)
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
1 P17125 (/IMP)
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
1 T0MJ72 (/ISS)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 P17125 (/IDA)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 G9KT38 (/ISS)
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
1 T0MJ72 (/ISS)
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
1 T0MJ72 (/ISS)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 P17125 (/IMP)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 P17125 (/ISO)
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
1 G9KT38 (/ISS)
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
1 G9KT38 (/ISS)
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
1 P17125 (/IMP)
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
1 P17125 (/ISO)
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
1 T0MJ72 (/ISS)
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
1 T0MJ72 (/ISS)
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
1 G9KT38 (/ISS)
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
1 G9KT38 (/ISS)
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
1 G9KT38 (/ISS)
Signal transduction by protein phosphorylation GO:0023014
A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
1 T0MJ72 (/ISS)
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
1 T0MJ72 (/ISS)
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
1 G9KT38 (/ISS)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
1 T0MJ72 (/ISS)
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
1 Q07258 (/NAS)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
1 G9KT38 (/ISS)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
1 P16047 (/TAS)
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
1 Q07258 (/IDA)
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
1 P17125 (/ISO)
Regulation of epithelial cell differentiation GO:0030856
Any process that modulates the frequency, rate or extent of epithelial cell differentiation.
1 Q07258 (/TAS)
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
1 P17125 (/IDA)
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
1 G9KT38 (/ISS)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
1 G9KT38 (/ISS)
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
1 T0MJ72 (/ISS)
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
1 G9KT38 (/ISS)
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
1 G9KT38 (/ISS)
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
1 P17125 (/ISO)
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
1 G9KT38 (/ISS)
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
1 G9KT38 (/ISS)
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
1 T0MJ72 (/ISS)
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
1 T0MJ72 (/ISS)
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
1 G9KT38 (/ISS)
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
1 P17125 (/ISO)
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
1 G9KT38 (/ISS)
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
1 T0MJ72 (/ISS)
Response to laminar fluid shear stress GO:0034616
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.
1 Q07258 (/IEP)
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
1 G9KT38 (/ISS)
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
1 Q07258 (/IEP)
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
1 G9KT38 (/ISS)
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
1 T0MJ72 (/ISS)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 Q07258 (/IDA)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 P17125 (/ISO)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
1 G9KT38 (/ISS)
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
1 G9KT38 (/ISS)
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
1 P17125 (/IMP)
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
1 T0MJ72 (/ISS)
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
1 G9KT38 (/ISS)
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
1 G9KT38 (/ISS)
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
1 G9KT38 (/ISS)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
1 Q07258 (/IDA)
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
1 P17125 (/ISO)
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
1 P17125 (/ISO)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
1 G9KT38 (/ISS)
Regulation of endothelial cell differentiation GO:0045601
Any process that modulates the frequency, rate or extent of endothelial cell differentiation.
1 Q07258 (/TAS)
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
1 G9KT38 (/ISS)
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
1 T0MJ72 (/ISS)
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
1 T0MJ72 (/ISS)
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
1 G9KT38 (/ISS)
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
1 T0MJ72 (/ISS)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
1 G9KT38 (/ISS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
1 P17125 (/ISO)
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
1 G9KT38 (/ISS)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
1 P17125 (/IGI)
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
1 P17125 (/IMP)
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
1 G9KT38 (/ISS)
Spleen development GO:0048536
The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions.
1 P16047 (/IEP)
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
1 Q07258 (/IEP)
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
1 P16047 (/IEP)
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
1 T0MJ72 (/ISS)
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
1 G9KT38 (/ISS)
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
1 Q07258 (/IDA)
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
1 P17125 (/ISO)
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
1 Q07258 (/IEP)
Regulation of epithelial cell proliferation GO:0050678
Any process that modulates the frequency, rate or extent of epithelial cell proliferation.
1 Q07258 (/TAS)
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
1 P17125 (/ISO)
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
1 T0MJ72 (/ISS)
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
1 G9KT38 (/ISS)
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
1 P17125 (/IMP)
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
1 P17125 (/ISO)
Positive regulation of timing of catagen GO:0051795
Any process that activates or increases the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
1 T0MJ72 (/ISS)
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
1 T0MJ72 (/ISS)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
1 G9KT38 (/ISS)
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
1 T0MJ72 (/ISS)
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 P16047 (/IMP)
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 T0MJ72 (/ISS)
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 P16047 (/TAS)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
1 P17125 (/IEP)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
1 P17125 (/ISO)
Frontal suture morphogenesis GO:0060364
The process in which the frontal suture is generated and organized.
1 Q07258 (/IEP)
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
1 P17125 (/IMP)
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
1 T0MJ72 (/ISS)
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
1 G9KT38 (/ISS)
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
1 P17125 (/IMP)
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 P17125 (/ISO)
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
1 G9KT38 (/ISS)
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
1 P17125 (/IDA)
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
1 G9KT38 (/ISS)
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
1 G9KT38 (/ISS)
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
1 G9KT38 (/ISS)
Mesenchyme migration GO:0090131
The process in which the population of cells that make up a mesenchyme undergo directed movement.
1 P16047 (/IMP)
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
1 G9KT38 (/ISS)
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
1 G9KT38 (/ISS)
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
1 P17125 (/ISO)
Positive regulation of tight junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of tight junction disassembly.
1 P17125 (/ISO)
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
1 G9KT38 (/ISS)

There are 29 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
88 A6QP91 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) D2GZY6 (/ISS) F1NRQ9 (/ISS) F1PR85 (/ISS) F6VL66 (/ISS) F7DR45 (/ISS) F7HDK4 (/ISS)
(78 more)
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
14 A5YM40 (/IDA) A5YM40 (/IDA) A5YM40 (/IDA) A5YM40 (/IDA) A5YM40 (/IDA) A5YM40 (/IDA) A5YM40 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
(4 more)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
7 P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS)
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
7 P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC)
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
7 P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS) P10600 (/TAS)
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
7 P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
2 G9KT38 (/ISS) T0MJ72 (/ISS)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
1 T0MJ72 (/ISS)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 Q07258 (/IDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 P17125 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 Q07258 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 P17125 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 G9KT38 (/ISS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 Q07258 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 P17125 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 G9KT38 (/ISS)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
1 Q07258 (/IDA)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
1 P17125 (/ISO)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
1 G9KT38 (/ISS)
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
1 Q07258 (/IDA)
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
1 P17125 (/ISO)
T-tubule GO:0030315
Invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril. The ends of T-tubules make contact with the sarcoplasmic reticulum membrane.
1 Q07258 (/IDA)
T-tubule GO:0030315
Invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril. The ends of T-tubules make contact with the sarcoplasmic reticulum membrane.
1 P17125 (/ISO)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
1 P17125 (/IDA)
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
1 Q07258 (/IDA)
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
1 P17125 (/ISO)
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
1 P17125 (/ISO)
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
1 P17125 (/ISO)
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
1 G9KT38 (/ISS)